CPHI vs ROL · rev $4.1M vs P/E 41, rev $3.39B
China Pharma Holdings Inc (CPHI) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
CPHI currently screens at market cap $29.0M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the CPHI and ROL stock pages for the full models.
Not investment advice.